stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) Return on invested capital
Alcon's return on invested capital over the twelve months to 30 June 2026 was 2.38%, down 1.0 percentage points from fiscal 2025 (3.38%). Over the past ten years it has ranged from −1.41% (fiscal 2020) to 3.62% (fiscal 2024); the current reading is higher than 90% of that period. That is above the Medical Instruments & Supplies industry median of 0.13% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 3.38% | (0.24) |
| FY2024 | 3.62% | 0.94 |
| FY2023 | 2.68% | 0.88 |
| FY2022 | 1.80% | 0.13 |
| FY2021 | 1.67% | 3.08 |
| FY2020 | −1.41% | (0.88) |
| FY2019 | −0.53% | 0.16 |
| FY2018 | −0.69% | (0.69) |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| RMD ResMed Inc. compare | 22.8% |
| WST West Pharmaceutical Services, Inc. compare | 18.0% |
| MDLN Medline Inc. compare | 17.8% |
| ALGN Align Technology, Inc. compare | 12.3% |
| BDX Becton, Dickinson and Company compare | 3.89% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| ALC Alcon | 2.38% |
| SOLV Solventum Corporation compare | 0.00% |
| BAX Baxter International Inc. compare | −1.05% |
| Medical Instruments & Supplies industry median | 0.13% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement